Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March.

Kenya officially announced the introduction of a groundbreaking long-acting injectable HIV prevention drug, Lenacapavir, ...

Kenya has received 21,000 starter doses of the HIV prevention injection Lenacapavir, marking a major milestone in the country’s efforts to curb new infections, particularly among young people.

Gilead Sciences posts strong 2025 HIV growth despite a $900M headwind, as Biktarvy and Descovy lead and new launch Yeztugo gains momentum.

In his State of the Nation address President Cyril Ramaphosa announced the rollout of Lenacapavir, a six-monthly HIV prevention injection, to over 450 000 people this year.

In his State of the Nation Address (SONA) this week, President Cyril Ramaphosa announced that the country will begin ...

"The price has been negotiated. Scotland has access. So why are people in England still waiting?" writes Dan Glass in an op-ed for Attitude The post ‘Lenacapavir is available – how many people have ...

Zimbabwe is preparing to make one of its boldest public‑health moves in decades - rolling out a groundbreaking HIV prevention injection that could ...

Yinjongo Yesizwe Foundation Executive Director Nontyatyambo Makapela says they are excited and welcome the announcement by President Cyril Ramaphosa around the massive rollout of the Lenacapavir ...

KZN Health MEC Nomagugu Simelane warns students about the dangers of inter-generational transactional relationships, urging them to focus on education and health over material temptations.

The Council for Global Equality and Physicians for Human Rights have filed a Freedom of Information Act lawsuit against the State Department for PEPFAR-related data and documents. The groups, which ...